Palmer v. Carroll

640 F. Supp. 2d 542, 2009 U.S. Dist. LEXIS 69292, 2009 WL 2423705
CourtDistrict Court, D. Delaware
DecidedAugust 6, 2009
DocketCiv. 06-576-SLR
StatusPublished
Cited by1 cases

This text of 640 F. Supp. 2d 542 (Palmer v. Carroll) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Palmer v. Carroll, 640 F. Supp. 2d 542, 2009 U.S. Dist. LEXIS 69292, 2009 WL 2423705 (D. Del. 2009).

Opinion

MEMORANDUM OPINION

ROBINSON, District Judge.

I. INTRODUCTION

Plaintiff Dale Otis Palmer (“plaintiff’), an inmate at the James T. Vaughn Correctional Center (‘VCC”), Smyrna, Delaware, filed this civil rights complaint pursuant to 42 U.S.C. § 1983. (D.I. 2, 6, 9, 50, 119) Presently before the court are the parties’ motions for summary judgment, motions for sanctions, motions to strike, and motion for extension of time. 1 (D.I. 268, 269, 273, 274, 275, 276, 277, 278, 279, 283, 287, 294, 301, 306, 307, 308) For the reasons set forth below, the court will deny plaintiffs motions for summary judgment, grant defendants’ motions for summary judgment and deny the remaining motions as moot.

II. BACKGROUND

Plaintiffs complaint was signed on August 3, 2006, postmarked September 13, 2006, and file-stamped September 14, 2006. (D.I. 2) Plaintiff was housed at the Sussex Correctional Institution (“SCI”), Georgetown, Delaware from May 15, 2003 until May 27, 2005, when he was transferred to the VCC, where he is currently housed. (D.I. 288, p. 2, ¶ 4)

Plaintiff testified that his complaint boils down to three issues: (1) the failure to receive a third injection required for a hepatitis B vaccine; (2) the failure to provide requested treatment for hepatitis C (“HCV”) with either interferon or ribavirin; and (3) the failure to receive a liver biopsy. (D.I. 286, app. 39-40) Medical records indicate that plaintiff suffers from *545 GERD (i.e., gastroesophageal reflux disease or acid reflux); allergic rhinitis, CKD (i.e., chronic kidney disease), stage III; 2 and hepatitis B and C. 3 (D.I. 282, ex. 24(a), D.I. 299, supp. app. 314) He tested positive for HCV in the late 1980s. (D.I. 292, ex. 1) HCV is a contagious liver disease that ranges in severity from a mild illness lasting a few months to a serious, lifelong illness that attacks the liver. (D.I. 286, ex. G)

Plaintiff is not the only inmate with hepatitis. He testified that certain inmates receive treatment, including biopsies. (D.I. 285, app. 3) The treatment received by an inmate depends upon the severity of the disease. (Id.) Plaintiff does not consider lab work treatment. (Id. at 15) According to defendant James Welch (“Welch”), director of health care services for the Delaware Department of Correction (“DOC”), during the relevant time period of the complaint, there was no prison policy concerning chronic diseases and/or housing guidelines. (D.I. 281, ex. 10)

On April 6, 2006, plaintiff wrote to defendant Thomas Carroll (“Carroll”), former warden at the VCC, requesting his help in obtaining treatment for hepatitis. (D.I. 281, ex. 2) The letter states, “I have tried to convince the medical doctors here at D.C.C. to give me a biopsy to determine if I have a liver disease from this hepatitis and they keep telling me I’m not sick enough.” (Id.) On July 7, 2006, Scott Altman (“Altman”), the quality assurance monitor for defendant Correctional Medical Services (“CMS”), carbon copied Carroll on a letter responding to plaintiffs request for information. (D.I. 281, ex. 1) Carroll does not recall receiving any letters from plaintiff. (D.I. 281, exs. 1(a), (b))

After he filed his complaint, plaintiff submitted additional written complaints on September 21, 2006, November 7, 2006, December 15, 2006, June 2, 2007, June 12, 2007, June 29, 2007, and January 6, 2008, to various individuals including the director of CMS, Carroll, the Commissioner of the DOC, and Welch requesting medical care for his hepatitis condition. (D.I. 281, exs. 3-8, 25(a)) In many instances, plaintiff carbon copied Carroll and/or Welch on the correspondence. According to Carroll, depending on the subject matter, inmate letters are forwarded to proper personnel for appropriate action. (D.I. 70, ¶ 2) Although Welch has replied to inmates’ letters, he usually does not. (D.I. 69, ¶ 14-15) If the letter concerns a medical problem, it is forwarded to the medical vendor. (D.I. 69, ¶ 14; D.I. 281, ex. 11)

Susan Schappell (“Schappell”) is a retired registered nurse who was employed by First Correctional Medical, Inc. (FCM). 4 She stated that hepatitis A and B vaccines were ordered for plaintiff on September 3, 2003. (D.I. 286, app. 21) Schappell administered the first dose of the hepatitis A vaccine on September 7, 2003, and the second dose on March 19, 2004. (Id. at 22-22a) Schappell adminis *546 tered the first dose of the hepatitis B vaccine on September 15, 2003, the second dose on October 29, 2003, and the third dose on March 19, 2004. (Id. at 21-22) Plaintiff does not recall receiving the third dose of the hepatitis B vaccine.

Defendant Iihoma Chuks (“Chuks”) is a nurse practitioner, currently employed by CMS, who began her employment with CMS in October 2005. (D.I. 286, app. 151) Prior to her CMS employment, she was employed by FCM from June 16, 2003 until April 2005. (Id. at 152) Chuks’ job duties do not authorize her to order a liver biopsy or prescribe interferon and/or ribavirin without the express authorization from an infectious disease physician. While Chuks states that she has never represented herself as a medical doctor, plaintiff contends that she has. (Id. at 152)

Medical records indicate that plaintiff was seen by Chuks on October 12, 2005 at the chronic care clinic where he complained of heartburn and foot pain. (D.I. 286, app. 168-69) She saw him on May 29 and June 1, 2007 for complaints of abdominal pain and toe pain. (D.I. 286, app. 163, 166) Chuks’ signature appears on physicians’ orders dated October 12, 2005, April 18, 2007, and June 1, 2007, and progress notes dated May 10, 2006, June 6, 2006, September 30, 2008, October 17, 2008, and November 6, 2008. (Id. at 164-5, 167, 175-77) Her name also appears on lab reports dated January 11, 2006, and May 4, 2007. (Id. at 172-74)

Defendant Dr. John Durst (“Dr. Durst”) treated patients in the chronic care clinic at the VCC from January 2006 through October or November 2006. (D.I. 186, app. 14) Dr. Durst, who is not an infectious disease specialist, does not treat some infectious diseases but, rather, undertakes investigative procedures. (D.I. 281, ex. 54(c)) No single test provides the only means for the diagnosis and treatment of hepatic disease. (D.I. 213, D.I. 281, ex. 53) Each test reflects a different type of investigation in formulating a medical opinion and treatment plan. (Id.) According to Dr. Durst, a liver biopsy is invasive and should be a means of last resort to determine what is wrong with a liver and how badly it is damaged. (Id.)

Dr. Durst ordered and reviewed lab work and monitored liver function tests and viral loads to determine if the results were within the normal reference range or elevated. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
640 F. Supp. 2d 542, 2009 U.S. Dist. LEXIS 69292, 2009 WL 2423705, Counsel Stack Legal Research, https://law.counselstack.com/opinion/palmer-v-carroll-ded-2009.